Cholesterol is required for endocytosis and endosomal escape of adenovirus type 2. by Imelli, N et al.
University of Zurich





Cholesterol is required for endocytosis and endosomal escape of
adenovirus type 2
Imelli, Nicola; Meier, Oliver; Boucke, Karin; Hemmi, Silvio; Greber, Urs F
Imelli, Nicola; Meier, Oliver; Boucke, Karin; Hemmi, Silvio; Greber, Urs F. Cholesterol is required for endocytosis
and endosomal escape of adenovirus type 2. J. Virol. 2004, 78(6):3089-98.
Postprint available at:
http://www.zora.unizh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.unizh.ch
Originally published at:
J. Virol. 2004, 78(6):3089-98
Imelli, Nicola; Meier, Oliver; Boucke, Karin; Hemmi, Silvio; Greber, Urs F. Cholesterol is required for endocytosis
and endosomal escape of adenovirus type 2. J. Virol. 2004, 78(6):3089-98.
Postprint available at:
http://www.zora.unizh.ch
Posted at the Zurich Open Repository and Archive, University of Zurich.
http://www.zora.unizh.ch
Originally published at:
J. Virol. 2004, 78(6):3089-98
Cholesterol is required for endocytosis and endosomal escape of
adenovirus type 2
Abstract
The species C adenovirus type 2 (Ad2) and Ad5 bind the coxsackievirus B Ad receptor and alphav
integrin coreceptors and enter epithelial cells by clathrin-mediated endocytosis. This pathway is rapid
and efficient. It leads to cell activation and the cholesterol-dependent formation of macropinosomes.
Macropinosomes are triggered to release their contents when incoming Ad2 escapes from endosomes.
Here, we show that cholesterol extraction of epithelial cells by methyl-beta-cyclodextrin (mbetaCD)
treatment reduced Ad5-mediated luciferase expression approximately 4-fold. The addition of cholesterol
to normal cells increased gene expression in a dose-dependent manner up to threefold, but it did not
restore gene expression in mbetaCD-treated cells. mbetaCD had no effect in the presence of excess
cholesterol, indicating that the inhibition of gene expression was due specifically to cholesterol
depletion. Cholesterol depletion inhibited rapid Ad2 endocytosis, endosomal escape, and nuclear
targeting, consistent with the notion that clathrin-dependent endocytosis of Ad2 is cholesterol
dependent. In cholesterol-reduced cells, Ad2 internalized at a low rate, suggestive of an alternative,
clathrin-independent, low-capacity entry pathway. While exogenous cholesterol completely restored
rapid Ad2 endocytosis, macropinocytosis, and macropinosome disruption, it did not, surprisingly,
restore viral escape from endosomes. Our results indicate that macropinosome disruption and endosomal
escape of Ad2 are independent events in cells depleted of and then refilled with cholesterol, suggesting
that viral escape from endosomes requires lipid-controlled membrane homeostasis, trafficking, or
signaling.
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The species C adenovirus type 2 (Ad2) and Ad5 bind the coxsackievirus B Ad receptor and v integrin
coreceptors and enter epithelial cells by clathrin-mediated endocytosis. This pathway is rapid and efficient. It
leads to cell activation and the cholesterol-dependent formation of macropinosomes. Macropinosomes are
triggered to release their contents when incoming Ad2 escapes from endosomes. Here, we show that cholesterol
extraction of epithelial cells by methyl--cyclodextrin (mCD) treatment reduced Ad5-mediated luciferase
expression 4-fold. The addition of cholesterol to normal cells increased gene expression in a dose-dependent
manner up to threefold, but it did not restore gene expression in mCD-treated cells. mCD had no effect in
the presence of excess cholesterol, indicating that the inhibition of gene expression was due specifically to
cholesterol depletion. Cholesterol depletion inhibited rapid Ad2 endocytosis, endosomal escape, and nuclear
targeting, consistent with the notion that clathrin-dependent endocytosis of Ad2 is cholesterol dependent. In
cholesterol-reduced cells, Ad2 internalized at a low rate, suggestive of an alternative, clathrin-independent,
low-capacity entry pathway. While exogenous cholesterol completely restored rapid Ad2 endocytosis, macropi-
nocytosis, and macropinosome disruption, it did not, surprisingly, restore viral escape from endosomes. Our
results indicate that macropinosome disruption and endosomal escape of Ad2 are independent events in cells
depleted of and then refilled with cholesterol, suggesting that viral escape from endosomes requires lipid-
controlled membrane homeostasis, trafficking, or signaling.
The plasma membrane is a major barrier for invading
agents. It is organized into microdomains coupling the entry of
receptor-bound ligands to the internal organization of the cell.
Viruses penetrate the plasma membrane by various mecha-
nisms, including lipid fusion and membrane perforation, or
they enter by receptor-mediated endocytosis, bypassing the
cortical actin network (27, 36, 55, 60). Endocytosis is crucial for
cell homeostasis, regulation of activation, and viral infection
(for recent reviews, see references 9, 15, and 44). All types of
endocytosis are harnessed by viruses (reviewed in references
40, 55, and 61). Clathrin-dependent endocytosis requires the
large GTPase dynamin, a variety of additional factors, and
sometimes also lipid rafts that are cholesterol dependent. It
originates at specialized plasma membrane regions where cy-
tosolic adaptor proteins bind the endocytic receptors and phos-
phoinositides, allowing the formation of clathrin coats (for a
recent review, see reference 31). Clathrin-dependent endocy-
tosis is used by a variety of enveloped viruses, such as Semliki
Forest virus (24), Sindbis virus (12), vesicular stomatitis virus
(71), Hantaan virus (29), and influenza virus (37), although for
the last a clathrin-independent pathway has also been pro-
posed (63). Clathrin-dependent endocytosis is apparently used
by nonenveloped viruses, such as parvoviruses (4, 54), human
rhinovirus type 2 (67), human papillomavirus types 16 and 58
(6), and human adenovirus type 2 (Ad2) and Ad5 (7, 16, 39, 42,
75, 76). With other viruses, the evidence for or against clathrin-
dependent endocytosis is not so clear.
Caveolar uptake and lipid raft-dependent pathways invari-
ably require cholesterol, and sometimes the coat protein
caveolin 1, and dynamin, a large GTPase implicated in pinch-
ing off the emerging membrane buds (reviewed in reference
74). Caveolae are flask-shaped invaginations of the plasma
membrane, important for cell signaling, cholesterol efflux, and
the uptake of cholesterol esters. In normal tissue culture cells,
caveolae do not pinch off, but simian virus 40, polyomavirus,
echovirus 1, and certain filoviruses can induce the internaliza-
tion of caveolae (reviewed in reference 55). Caveolin-indepen-
dent uptake can be dynamin dependent, as in the case of the
interleukin 2 receptor (33) or intercellular adhesion molecule
1 (43). Intercellular adhesion molecule 1 serves as a receptor of
the major group of human rhinoviruses and coxsackievirus A21
(reviewed in references 5 and 27), implying that these agents
can be taken up by uncoated membranes. In turn, caveolin-
independent uptake can be independent of dynamin, e.g., the
raft-dependent macropinocytosis (10, 23, 39) and a less well-
characterized raft-independent endocytic pathway (30, 51). In-
terestingly, virus-like particles of human papillomavirus type
16 appear to enter Langerhans cells by a clathrin- and mac-
ropinocytosis-independent pathway but enter dendritic cells by
a clathrin-dependent pathway, indicating cell-type-specific dif-
ferences (14). Macropinocytosis in turn has a key role in the
entry of Chlamydia, Salmonella, Shigella, and Brucella bacteria
(49, 53, 77) and perhaps human immunodeficiency virus type 1
(34). It is induced by growth factor stimulation or downstream
signaling molecules in epithelial cells, fibroblasts, neutrophils,
macrophages, and dendritic cells and leads to the closure of
lamellipodia at ruffling membranes, thus engulfing large areas
of plasma membrane (25).
Given that viruses enter by various endocytic pathways, the
question of how a particular pathway is selected arises. Besides
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cell-type-specific aspects, crucial determinants are the cell sur-
face receptors and coreceptors. Serotypes of the human Ad
species A, C, D, E, and F bind the coxsackievirus B Ad recep-
tor (CAR) (59), whereas serotypes of the two species B1 and
B2 use the membrane cofactor CD46 as a receptor (17, 62; D.
Sirena, B. Lilienfeld, M. Eisenhut, S. Kaelin, K. Boucke, R. R.
Beerli, L. Vogt, C. Ruedl, M. F. Bachmann, U. F. Greber, and
S. Hemmi, submitted for publication). While the internaliza-
tion pathways of the species B Ads are unknown, the species C
Ads are internalized into epithelial cells through clathrin-
dependent endocytosis activated by v3 or v5 integrin
coreceptors (for reviews, see references 40 and 48). Recent
evidence suggests that CAR is associated with GM1 ganglio-
side-containing lipid raft microdomains that are disrupted by
the cholesterol-binding reagent methyl--cyclodextrin
(mCD), thus inhibiting infection (3).
Here, we show that cholesterol is required for rapid Ad2
endocytosis, macropinocytosis, viral escape, and infection. In
cholesterol-reduced cells, we find evidence of a slow Ad2 in-
ternalization pathway delivering low levels of virus to the cy-
tosol. Surprisingly, cholesterol replacement did not restore in-
fection and viral escape from endosomes, although it restored
endocytosis, macropinocytosis, and macropinosomal disrup-
tion, implying that cholesterol-dependent membrane traffick-
ing is directly or indirectly implicated in Ad2 escape from
endosomes. These results raise the notion that the entry of
both nonenveloped and enveloped viruses, as well as bacterial
pathogens (8, 32, 56), can be dependent on cellular cholesterol.
MATERIALS AND METHODS
Cells, viruses, plasmids, and proteins. HeLa cells (human cervical epitheloid
carcinoma cells) were grown in Dulbecco’s modified Eagle’s medium (DMEM)
(Gibco-BRL, Basel, Switzerland) containing 7% clone III serum or 7% fetal
bovine serum (HyClone; Integra BioSciences AG, Zu¨rich, Switzerland), 1%
nonessential amino acids, and 1% glutamine (Gibco-BRL). Ad2 and [35S]me-
thionine-labeled Ad2 were purified and labeled with Texas Red (TR) as de-
scribed previously (18, 21, 47). Cell binding of [35S]methionine-labeled Ad2
(75,000 cpm per l) was performed as described previously (39). ts1 Ad2 (a
temperature-sensitive virus lacking functional p23 protease) (78) was produced
as described previously (20). Ad5-Luc (with the E1A and E1B regions deleted
and containing the firefly luciferase gene (luc) under the control of the major
cytomegalovirus [CMV] promoter) was used as described previously (35). The
pAd-CMV-luc plasmid was supplied by D. Sirena (University of Zu¨rich). Ad2
fiber knob (0.4 mg/ml) and cyclic arginine-glycine-aspartate peptide (cRGD; 0.1
mM) were used as reported previously (70). The mouse monoclonal anti-CAR
antibody E1-1 (13) and the function-blocking anti-v integrin mouse monoclonal
antibody 17E6 (41) were employed as described previously (45).
Metabolic labeling. HeLa cells grown in 35-mm-diameter dishes were incu-
bated in methionine-free, serum-free medium (Gibco) at 37°C for 20 min and
pulse-labeled with 5 Ci of Tran-[35S]-Label (1,175 Ci/mmol; ICN Biochemicals)
for 40 min, extensively washed with phosphate-buffered saline (PBS), and lysed
in 1 ml of Ripa buffer (20 mM Tris-HCl, pH 7.4, 130 mM NaCl, 2 mM EDTA,
0.1% sodium dodecyl sulfate, 0.5% deoxycholate, 1% Triton X-100) containing
protease inhibitors (1 mM phenylmethylsulfonyl fluoride and 1 g each of chy-
mostatin, leupeptin, aprotinin, and pepstatin/ml) at 4°C for 30 min as described
previously (46). The lysate was precipitated with trichloroacetic acid (15% [wt/
vol]) on ice for 30 min and centrifuged at 16,000 g for 10 min at 4°C. The pellet
was washed in ice-cold acetone, centrifuged, air dried, dissolved in 200 l of 0.1
M Tris (pH 8.1) containing 1% sodium dodecyl sulfate, and analyzed in a liquid
scintillation counter (Beckman) as described previously (73).
Luciferase activity. Ad5-Luc was titrated by plaque assays on 911 cells ex-
pressing E1 proteins (45). It was bound to HeLa cells in 24-well dishes in cold
RPMI-bovine serum albumin (BSA) for 1 h and internalized in DMEM-BSA at
37°C for various times. The cells were washed with PBS and lysed in 400 l of
buffer mixture (Promega), and luciferase activity was quantitated as described
previously (35). The results were normalized to the cell numbers for each con-
dition as determined in parallel samples using crystal violet. The activity of CMV
promoter-controlled luciferase DNA was determined upon electroporation of 5
g of pAd-CMV-luc DNA per 106 cholesterol-depleted or normal cells (Nucleo-
fector; Amaxa GmbH, Cologne, Germany).
Cholesterol depletion and replacement. HeLa cells grown in 35-mm-diameter
dishes to 80% confluency had their cholesterol reduced either with 4 M lova-
statin (LOV; Merck, Darmstadt, Germany) and 0.25 mM mevalonate (MEV;
Sigma, Fluka, Switzerland) for 4 days in regular growth medium or with mCD
(50 mM) in RPMI–0.2% BSA for 20 min at room temperature (25°C). Cell-
associated cholesterol was measured by detaching the cells with 40 mM EDTA
in PBS (without calcium and magnesium) at 4°C for up to 40 min. The cells were
centrifuged at 1,000  g for 2 min, resuspended in 100 l of reaction buffer
(Amplex Red cholesterol assay kit; Molecular Probes), and homogenized
through a 20-gauge needle, followed by measurement of cholesterol using a
spectrofluorometer (model 1420 Multilabel Counter; Wallac Victor, Turku, Fin-
land) at 560-nm excitation and 590-nm emission wavelengths according to the
manufacturer’s conditions and published literature (2). Cholesterol replacement
occurred with 0.1 mM water-soluble cholesterol (C-4951; Sigma) in RPMI–0.2%
BSA at 37°C for 15 min.
Fluorescence microscopy. Cholesterol staining with filipin was performed in
HeLa cells fixed with 3% paraformaldehyde for 20 min, washed with PBS and 25
mM ammonium chloride in PBS, and incubated with filipin (100 g/ml; Sigma)
for 2 h at 4°C, following earlier protocols (68). Coverslips were mounted in
DAKO fluorescence mounting medium (DAKO Corp., Carpinteria, Calif.) and
observed in an upright fluorescence microscope (Polyvar; Merck Corp.)
equipped with a 350-nm excitation filter and a 420-nm emission filter. Images
were recorded as described previously (18). Confocal laser scanning microscopy
(CLSM) was performed on a DM RXA2 TCS SP2 AOBS microscope (Leica
Microsystems, Wetzlar, Germany) equipped with an Ar-ArKr laser, a He-Ne
543-594 laser, a He-Ne 633 laser, a diode laser at 405 nm, and a 63 oil
immersion objective (N.A. 1.4 PL APO). The pinhole value was 1.0, airy 1,
yielding optical sections of 0.48 m with a voxel of 0.233 by 0.233 by 0.48 m.
The zoom factor was 2. Image processing was performed with Leica and Pho-
toshop software (Adobe). Quantifications of the fluorescence intensities of
Ad2-TR (1 g of Ad2-TR was used per 12-mm-diameter regular coverslip during
cold binding) in different subcellular regions were carried out on complete stacks
of optical sections obtained by a far-field fluorescence microscope (Leica DM-
IRBE), and deconvolution was done by the Metamorph Software package (Uni-
versal Imaging Corp.) as described previously (47).
Fluid phase endocytosis and flow cytometry. Fluid phase endocytosis was
determined as described previously (39). Briefly, cells were incubated with Ad2
(40 g/ml) in the cold, washed, and incubated with warm RPMI-BSA for 5 min,
followed by a pulse with warm RPMI-BSA containing dextran-fluorescein iso-
thiocyanate (FITC) (1 mg/ml) for 5 min and a chase in the absence of dextran for
5 min. Alternatively, cells were treated with phorbol myristate acetate (PMA; 200
nm) during the dextran pulse or were left unstimulated. After the chase, the cells
were washed in cold RPMI-BSA and acid stripped in 0.1 M sodium acetate–0.05
M NaCl (pH 5.5) and detached with trypsin, and at least 10,000 viable cells were
analyzed by flow cytometry in an Epics XL sorter (Beckman Coulter, Miami,
Fla.). Dextran-FITC release from endosomes was quantitated by visual inspec-
tion of cells on glass coverslips using an upright fluorescence microscope (Poly-
var; Merck) equipped with 40 optics as described earlier (19). Release-positive
cells had a glowing green fluorescent phenotype. Dextran release from endo-
somes was verified using CLSM as described above. Cell surface CAR and v
integrins were determined by flow cytometry as described previously (45).
Briefly, 106 cells were detached from the 35-mm-diameter dishes with 20 mM
EDTA in PBS for 15 min, washed, and incubated with anti-v or anti-CAR
mouse monoclonal antibody at 4°C for 1 h. After being washed in RPMI-BSA,
the cells were incubated with a rabbit anti-mouse immunoglobulin G coupled to
phycoerythrin (20 g/ml) at 4°C for 1 h, washed, resuspended in 0.3 ml of 2%
fetal bovine serum in PBS, and analyzed by flow cytometry.
Transmission electron microscopy (TEM). After cold binding to Ad2 (80
g/ml; multiplicity of infection [MOI], 10,000) for 1 h, washing, and internaliza-
tion as appropriate, cells were fixed in 2% formaldehyde–1.5% glutaraldehyde in
0.1 M sodium cacodylate buffer, pH 7.4 (CaCo) overnight and washed several
times in CaCo, followed by postfixation in 1% OsO4 (Electron Microscopy
Sciences) and 1.5% potassium ferricyanide (FeK3N6) in double-distilled H2O at
4°C for 60 min (modified according to the method of Simionescu and Simionescu
[64]). Specimens were rinsed in 0.1 M sodium cacodylate, contrasted with 1%
tannic acid in 0.05 M sodium cacodylate at room temperature for 45 min, washed
in 1% sodium sulfate, rinsed in H2O, stained in 2% uranylacetate in H2O
overnight, and embedded in Epon as described previously (46). Virus particles
were quantified at 50,000 magnification in ultrathin sections at the plasma
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membrane, endosomes, and cytosol viewed in a transmission electron micro-
scope (Zeiss EM 902A) at an acceleration voltage of 80,000 V (46).
Statistical analyses. Results were expressed as the mean values from, typically,
three experimental samples, including the standard error of the mean and sig-
nificance calculation by one-sided t tests.
RESULTS
Cholesterol has a key role in organizing sphingolipid rafts
that serve as platforms of cell signaling, protein organization,
and sorting. Its homeostasis is tightly controlled by spontane-
ous efflux, synthesis in the endoplasmic reticulum, and recep-
tor-mediated uptake of lipoproteins (38, 65). The rate-limiting
enzyme in cholesterol synthesis is 3-hydroxy-3-methylglutaryl
coenzyme A reductase, which can be inhibited by LOV (72).
Here, we sought to determine the basis of the requirement for
cholesterol for infection of epithelial cells with species C Ads.
Cholesterol reduction inhibits Ad5 gene expression. Choles-
terol levels were assessed in HeLa cells treated for 4 days with
LOV, in combination with MEV to ensure cell survival (66).
Alternatively, cholesterol was extracted from the plasma mem-
brane by mCD for 20 min. While the MEV-LOV treatment
reduced cholesterol by 20%, mCD or mCD plus MEV-
LOV lowered cholesterol by 45 and 55%, respectively, as in-
dicated by Amplex Red quantifications (Fig. 1A). This loss of
cholesterol was readily reversed by the addition of cholesterol
for 15 min (Fig. 1B). We noticed that the combined application
of mCD and MEV-LOV led to considerable cell stress, i.e.,
cells started to detach from the glass coverslips. Treatment
with mCD alone, however, had no effect on cell loss and
viability, as indicated by the measurement of [35S]methionine
incorporation into mCD-treated and control cells (Fig. 1C).
In fact, mCD-treated cells had reduced filipin staining in the
cell periphery but not in internal regions compared to control
cells, suggesting that peripheral cholesterol had been prefer-
entially reduced, in agreement with the overall cholesterol
measurements by Amplex Red (Fig. 1D).
We next measured Ad5-mediated transduction in cells
treated with mCD. mCD inhibited the expression of CMV
promoter-driven luc in a dose-dependent manner, maximally
fourfold at 25 or 50 mM measured at 4 h p.i. (Fig. 2A). In the
presence of 0.05 mM cholesterol, low concentrations of mCD
(5 mM) had no effect, indicating that the mCD inhibition
was due to cholesterol reduction rather than to nonspecific
effects. In the absence of mCD, cholesterol increased gene
expression up to threefold compared to untreated cells, further
supporting the notion that cholesterol is important for Ad5-
mediated gene expression. The mCD (50 mM) inhibition was
strongest at a high MOI of 1,000 (Fig. 2B), and it persisted for
up to 16 h postinfection (p.i.) at a level of at least twofold in
cells infected at a lower MOI of 100 (Fig. 2D), similar to an
earlier report (3). It was unlikely that mCD inhibited the
CMV promoter, since neither mCD nor cholesterol affected
the CMV-luc activity in transiently transfected HeLa cells (Fig.
2C). Surprisingly, restoring the cholesterol levels of mCD-
treated cells did not fully rescue Ad5 transduction (Fig. 2B).
Ad5 transduction of both normal and mCD-treated cells,
however, was dependent on v integrins and CAR, as indi-
cated by 3- and 10-fold inhibition with cRGD peptides and
soluble fiber knob, respectively (Fig. 2E). The effect of fiber
knob was not enhanced by mCD, suggesting that knob and
cholesterol were acting at the same point, e.g., CAR localized
in cholesterol raft domains. Accordingly, the function blocking
anti-CAR antibody E1-1 inhibited 35S-Ad2 binding to control
cells, mCD-treated cells, and cells with cholesterol replaced
to similar extents (Fig. 3A). Note that the apparent reduction
of virus binding to mCD-treated cells had low statistical sig-
nificance compared to binding to control cells (P 0.05; t test).
In contrast, the inhibition of gene expression by cRGD pep-
tides was additive to the mCD inhibition, suggesting that
RGD-binding integrins accessed by Ad5 perhaps occur in both
raft and nonraft domains (Fig. 2E). Importantly, v integrins
were readily detectable in both normal and cholesterol-re-
FIG. 1. Reduction of cellular cholesterol by mCD. (A) Choles-
terol was measured enzymatically by determination of cholesterol ox-
idase activity using an Amplex Red readout in HeLa cells incubated
with the cholesterol synthesis inhibitor LOV plus MEV or mCD.
(B) MEV-LOV- plus mCD-treated cells were refilled with 0.1 mM
cholesterol (Ch) for 15 min, followed by Amplex Red measurement.
(C) Biosynthetic activity of control and mCD-treated cells by deter-
mination of [35S]methionine incorporation, showing the mean values
of three samples from one representative experiment. (D) Filipin
staining of control and mCD-treated cells, including Nomarski im-
ages (top). The error bars indicate the corresponding standard errors
of the mean.
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duced cells, using a function-blocking anti-v integrin anti-
body, despite a small reduction by 25% upon mCD treat-
ment (Fig. 3B). These results reinforce the notion that the
cellular cholesterol balance is critical for Ad transduction.
Ad2 endocytosis requires cholesterol. We next analyzed viral
endocytosis in mCD-treated and control cells using quantita-
tive TEM. At 15 min p.i., 13% of the viral particles were found
in endosomes, 25% in the cytosol, and 60% at the plasma
membranes of control cells (Fig. 4A and B). This corresponded
well with biochemical internalization assays using surface
trypsinizations at low MOIs (21), confirming the validity of the
high-MOI EM approach. This in situ analysis was necessary,
since trypsinization of mCD-treated cells caused severe cell
damage (not shown). In contrast to control cells, Ad2 inter-
nalization was strongly inhibited in the cholesterol-reduced
cells, with only a few percent of the particles in endosomes and
in the cytosol (Fig. 4A and B). About 80% or more of the
plasma membrane-associated virus particles of control and
FIG. 2. Ad5-mediated gene delivery, but not plasmid DNA, is affected by cholesterol depletion and replacement. HeLa cell were incubated with
cholesterol (Ch), mCD, or mCD followed by cholesterol replacement (mCD3 0.1mM Ch). Ad5-Luc was bound in the cold, and the cells were
washed as described in Materials and Methods. The results are expressed as luciferase light units (l.u.) normalized to the corresponding cell
numbers obtained by crystal violet measurements of parallel samples. (A) Dose dependence of mCD and cholesterol treatments 4 h p.i.
(B) Cholesterol depletion affects Ad5-Luc gene expression at different MOIs 4 h p.i. (C) Lack of effect of cholesterol depletion on luciferase
expression of plasmid DNA in cells treated with mCD or cholesterol 8 h posttransfection (p.t.) and assayed for luciferase expression 40 h p.t.
(D) Time course of Ad5-Luc gene expression in control and cholesterol-depleted cells. (E) Fiber knob and cRGD peptides inhibit Ad5-Luc gene
expression in control and cholesterol-depleted cells 4 h p.i. 	, not present; , present. The error bars indicate the corresponding standard errors
of the mean.
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mCD-treated cells were localized in smooth regions, and18
and 13% were in plasma membrane lattices, i.e., electron-
dense flat domains associated with clathrin (Fig. 4C) (69).
About 3 and 1% of the plasma membrane-associated particles
were in coated pits of control and mCD-treated cells, respec-
tively. The levels of coated-pit-associated virus that were re-
covered in cholesterol-replaced cells were similar to those of
control cells. These results are consistent with the notion that
cholesterol depletion blocks clathrin-mediated endocytosis of
Ad2. Cholesterol replacement, in turn, restored virus localiza-
tion to clathrin-coated pits, allowing virus internalization (Fig.
4).
Macropinocytosis and Ad2 delivery to the cytosol depend on
cholesterol. Ad2 triggers the formation of macropinosomes
and the delivery of fluid phase contents into the cytosol, which
is due to virus-induced macropinosomal leakage (39). Using
flow cytometry, we found that the Ad2-induced fluid phase
endocytosis of 10-kDa dextran labeled with FITC was com-
pletely blocked in mCD-treated cells, similar to PMA-in-
duced fluid phase endocytosis (Fig. 5A) and consistent with an
earlier report demonstrating cholesterol dependence of growth
FIG. 3. Ad2 binding to normal and cholesterol-depleted cells de-
pends on CAR. (A) HeLa cells were treated with mCD, and choles-
terol (Ch) was replaced. The cells were incubated with the anti-CAR
antibody E1-1 and [35S]methionine-labeled Ad2 in the cold and exam-
ined for cell-associated virus by liquid scintillation counting. (B) Con-
trol and mCD-treated cells were examined for cell surface v inte-
grins by flow cytometry using the function-blocking 17E6 antibody and
secondary phycoerythrin-conjugated antibodies. The results are ex-
pressed as means of fluorescence. 	, not present; , present. The
error bars indicate the corresponding standard errors of the mean.
FIG. 4. Ad2 endocytosis is inhibited in cholesterol-depleted cells. (A) Ad2 was bound to control cells, mCD-treated cells, or mCD-treated
cells with cholesterol replaced (mCD 3 0.1mM Ch) and was internalized for 15 min, fixed, and prepared for TEM analysis. The arrowheads
indicate plasma membrane-associated virus, the arrows indicate endosomal virus, the double arrowheads indicate cytosolic virus, and the solid
arrowheads point out Ad2 particles at clathrin lattices (69). (B) Quantitative analyses of Ad2 at the plasma membrane (PM), in endosomes, and
in the cytosol expressed as percentages of total particles, with n representing the number of Ad2 particles analyzed. (C) Analyses of Ad2 in smooth
plasma membrane regions, in clathrin lattices, and in coated pits expressed as percentages of plasma membrane-associated particles. The error bars
indicate the corresponding standard errors of the mean.
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factor-activated macropinocytosis (23). The Ad2- and PMA-
induced dextran uptake could be readily restored by choles-
terol replacement. We then investigated whether dextran was
delivered into the cytosol by using fluorescence microscopy of
single cells. The results indicated that 75% of the Ad2-in-
fected cells contained cytosolic dextran-FITC, as indicated by
strong homogeneous fluorescence across the cytoplasm and
the nucleus (Fig. 5B and C). Uninfected cells or epidermal
growth factor-activated cells had punctate cytoplasmic dextran
fluorescence but no intranuclear signals. Likewise, 70% of
the Ad2- and mCD-treated cells were lacking nuclear dex-
tran-FITC. Dextran delivery to the cytosol could be completely
restored in cells with cholesterol replaced, indicating that Ad2-
induced macropinosomal leakage was restored.
Next, we analyzed the delivery of Ad2 particles from endo-
somes to the cytosol in quantitative EM experiments at 70 min
p.i. In control cells,80% of the cell-associated Ad2 was in the
cytosol, 7% was on the plasma membrane, and 11% was in
endosomes (Fig. 6A). In contrast, mCD-treated cells had
50% less cytosolic Ad2 than control cells (Fig. 6B). Very few
particles were found at the nuclear membrane, unlike in con-
trol cells (not shown). More than 40% of the particles were left
at the plasma membrane, and only 15% were in endosomes,
confirming that cholesterol depletion inhibited viral endocyto-
sis. As expected, the numbers of cytosolic particles at the
plasma membrane were low in cells with cholesterol replaced
(12%), but surprisingly, the endosomal levels were as high as
47% and the cytosolic particles remained at 41%, similar to the
cells without cholesterol replacement (Fig. 6C). Interestingly,
most of the endosomal Ad2 was found in large vesicles that
were often multivesiculated, consistent with late endosomes or
lysosomes. These results indicated that cholesterol replace-
ment restored Ad2 endocytosis but failed to efficiently deliver
particles to the cytosol. We also analyzed whether the uptake
of ts1, a mutant Ad2 that is inhibited at endosomal escape (20,
78), is cholesterol dependent. ts1 bears a point mutation in the
viral protease which blocks the processing of at least three viral
capsid proteins and three core proteins. ts1 was found to be
endocytosed efficiently in control cells, leaving 3% of the par-
ticles at the plasma membrane and 70% in predominantly large
endosomes (Fig. 6D). This was in good agreement with bio-
chemical measurements of internalization and lysosomal deg-
radation, the latter being sensitive to the treatment of cells
with leupeptin, an inhibitor of acid proteases (20). In mCD-
treated cells, ts1 internalization was somewhat inhibited, leav-
ing 18% of the particles at the plasma membrane (Fig. 6E).
The effect, however, was 3-fold less prominent than with
wild-type (wt) Ad2, suggesting that ts1 might internalize on a
pathway that is rather insensitive to cholesterol depletion. ts1
binds CAR and is internalized in an RGD peptide-sensitive
FIG. 5. Cholesterol-dependent Ad2-stimulated macropinocytosis and delivery of fluid phase endosomal contents to the cytosol. (A) Control
cells, mCD-treated cells, or mCD-treated cells with cholesterol replaced (mCD3 0.1mM Ch) were incubated with Ad2 in the cold, washed,
internalized at 37°C in the presence of dextran-FITC for 15 min, and analyzed by flow cytometry. (B) The internalized dextran was compared to
the dextran internalization in PMA-treated cells and was normalized to uninfected, unstimulated cells. Dextran release to the cytosol of cells pulsed
with dextran-FITC for 15 min and chased in the absence of dextran for 30 min was analyzed by fluorescence microscopy, and the number of cells
with dextran-positive nuclei was determined. (C) Examples of control cells containing endosomal dextran (punctate signals [a, c, and g]) and
cytosolic dextran (e and i) were imaged by CLSM, and total projections are shown, including the corresponding Nomarski images (b, d, f, h, and
k). Bar 
 10 m. The error bars indicate the corresponding standard errors of the mean.
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manner (20), albeit without cell activation (70). This pathway
may be similar to the uptake of low levels of wild-type Ad2 in
cholesterol-depleted cells (Fig. 6).
We also measured cytoplasmic transport of incoming Ad2
labeled with TR in control and cholesterol-depleted cells, us-
ing quantitative fluorescence microscopy. This approach gives
good indirect indications of endosomal escape of Ad2, as
shown in the case of the endosomal ts1, which is not delivered
to the nuclear region, unlike wt Ad2 (47). Cells treated with
mCD or with MEV-LOV plus mCD accumulated signifi-
cantly fewer Ad2 particles in the nuclear and perinuclear re-
gions than control cells (Fig. 7 and data not shown), in agree-
ment with defective viral escape from endosomes. Cholesterol
replacement in turn had no effect at 90 min p.i. and partially
rescued nuclear targeting of Ad2-TR at 135 min p.i. (not
shown). These measurements confirmed that cholesterol is
required for efficient entry and nuclear targeting of Ad2 in
epithelial cells.
DISCUSSION
Many ways lead into a cell, but specific pathways elicit patho-
gen infection of particular cell types. Here, we have shown that
endocytosis and endosomal escape of species C Ad2 and Ad5
in epithelial cells require cholesterol. In normal cells, Ad2
rapidly enters through the clathrin pathway, leading to viral-
gene expression (39). Supplementing the normal growth me-
dium with cholesterol was shown here to further enhance Ad5
transgene expression. In contrast, cells depleted of cholesterol
internalized Ad by a slow and inefficient pathway, with limited
particle delivery to the cytosol. Cholesterol depletion also af-
fected Ad5 gene expression, depending on the virus dose, with
inhibitions of 29, 51, and 75% at MOIs of 10, 100, and 1,000,
respectively. This differential requirement for cholesterol
could be due to different entry pathways at low and high MOIs.
Alternatively, it is possible that the low levels of cellular cho-
lesterol after mCD treatment suffice for virus uptake and
infection at low MOIs but become limiting at high MOIs. The
slow uptake of high-MOI Ad2 in cholesterol-reduced cells is
similar to the internalization of anthrax toxin, which oligomer-
izes in lipid rafts and is internalized by rapid clathrin-mediated
endocytosis, whereas monomeric toxin is internalized slowly
(1). Furthermore, the slow cholesterol-independent entry path
of Ad2 resembles the uptake of the Ad2 ts1 mutant in normal
cells. ts1 is defective at endosomal escape, cycles between
endosomes and the plasma membrane, and is degraded in
lysosomes (20). Its uptake is CAR and integrin dependent but
cholesterol independent.
Recently, CAR has been colocalized with the glycosphingo-
lipid GM1 labeled with cholera toxin B subunit in cholesterol-
rich membrane domains, distinct from caveolin domains (3,
52). Although it is not known if CAR is endocytosed, it has
been suggested that CAR is in a network of proteins and
specialized lipids that may undergo endocytosis, depending on
the intactness of the domain, extracellular ligands, or intracel-
lular activation. Likewise, the integrin coreceptors can be lo-
calized to lipid rafts, e.g., upon activation, as shown for the
leukocyte-associated LFA-1 (L2) integrin (26). It is unclear,
however, if integrins directly associate with rafts, since they
lack the palmitoyl modifications typical of many raft- and
FIG. 6. Cholesterol depletion inhibits endosomal escape of Ad2
but does not affect endocytosis of ts1. wt Ad2 or ts1 Ad2 was bound to
control HeLa cells, mCD-treated HeLa cells, or mCD-treated HeLa
cells with cholesterol replaced (mCD 3 0.1mM Ch) in the cold,
internalized for 70 min, and analyzed by TEM. Virus particles at the
plasma membrane (PM), in endosomes (endos), and in the cytosol
(Cyt) were quantitated as described in the legend to Fig. 4. The
analysis of total endosomal virus (tot) included the determination of
particles in small endosomes (s; 150-nm diameter), medium-size
endosomes (m; 300-nm diameter), and large multivesicular endo-
somes (l;,300-nm diameter). The error bars indicate the correspond-
ing standard errors of the mean.
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sphingolipid-associated proteins. Possibly, integrins localize to
rafts indirectly, as shown, e.g., for v3 integrin complexed
with tetraspanning and integrin-associated proteins (22). Thus,
cholesterol extraction from the plasma membrane is likely to
disturb the organization of lipid rafts necessary for efficient
CAR- and integrin-dependent entry of Ad2.
Typically, cholesterol depletion blocks caveolar endocytosis
and the uptake of other lipid raft-enriched plasma membrane
domains (55), consistent with the notion that some lipid raft
markers can be internalized without clathrin-coated pits (50).
Other markers, such as analogues of sphingomyelin, however,
are taken up approximately equally by clathrin-dependent and
-independent pathways (57). Further studies have shown that
clathrin-coated vesicles, and by inference clathrin-coated pits,
contain cholesterol, indistinguishable from other plasma mem-
brane regions (68). In fact, clathrin-mediated endocytosis of
transferrin receptor and epidermal growth factor receptor is
inhibited in cholesterol-depleted cells without affecting back
trafficking of the receptor to the surface (58, 69). The obser-
vation that flat coated membranes accumulate in mCD-
treated cells suggested that cholesterol is needed to induce
curvature of the membrane and detachment of coated pits
from the surface. Consistent with this observation, we have
found that wt Ad2 localized threefold less frequently to coated
pits in cholesterol-depleted cells than in control cells or cells
with cholesterol replaced. The coated pits that we observed in
the cholesterol-depleted cells appeared to be of regular shape.
Together, these results support the notion that the rapid clath-
rin-mediated Ad2 endocytosis requires cholesterol. Whether it
requires additional raft components is unknown. These results
are similar to a recent report on the minor receptor group
using human rhinovirus 2, which enters cells in a cholesterol-,
dynamin-, amphiphysin-, and AP180-dependent manner, indic-
ative of the clathrin-coated-pit pathway (67). The slow choles-
terol-independent endocytic pathway of Ad2, in turn, may be
independent of clathrin. Accordingly, Ad particles infecting
CAR-expressing epithelial cells were found in both clathrin-
associated and non-clathrin-associated membranes (3, 21, 46),
although the clathrin-associated pathway leads to infection (39,
75). This supports the notion that Ad2 can use multiple path-
ways into the cell and that in undisturbed cells the clathrin
pathway predominates over the other entry pathways.
Besides using clathrin-mediated endocytosis and a slow cho-
lesterol-independent entry pathway, incoming species C Ads
activate macropinocytosis (39). Macropinocytosis is indepen-
dent of dominant-negative dynamin K44A and is blocked by
protein kinase C inhibitors and the sodium-proton exchange
inhibitor amiloride. It is not required for Ad2 internalization,
and it releases fluid phase contents into the cytosol when virus
escapes from endosomes (39, 46). Macropinocytosis was not
observed in cholesterol-depleted cells, and no fluid phase
markers were delivered to the cytosol in the presence of Ad2,
consistent with the earlier notion that growth factor-activated
macropinocytosis is cholesterol dependent (23). Cholesterol
repletion readily restored the rapid Ad2 endocytosis and mac-
ropinocytosis, and also the release of macropinosomal contents
to the cytosol, but it did not restore viral escape from endo-
somes and gene expression. The depletion of cholesterol sev-
eral hours before infection, followed by washout of the drug,
however, has no effect on Ad5 transduction (3). Likewise, the
addition of extra cholesterol to control cells even enhanced
viral-gene expression. It is possible that the acute supply of
FIG. 7. Nuclear targeting of Ad2-TR is inhibited in cholesterol-depleted cells. Ad2-TR was bound to control or mCD-treated HeLa cells in
the cold and internalized for different times as indicated. The cells were fixed, and the subcellular distribution of Ad2-TR was determined by
quantitative microscopy. The results are expressed as fluorescence per unit area. Representative examples of cells fixed at 0 and 60 min p.i. are
shown in the inset. The nuclei are stained with 4,6-diamidino-2-phenylindole (blue). Bar 
 10 m. The error bars indicate the corresponding
standard errors of the mean.
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cholesterol to the depleted cells affected the proper lipid or-
ganization necessary for viral escape from endosomes (38).
Cholesterol replacement may not entirely restore the function-
ality of Ad-containing endosomes. Likewise, intracellular-
membrane trafficking may be altered in the restored cells. This
is based on the observation that an excess of cholesterol can be
transported from the plasma membrane to the endoplasmic
reticulum, where cholesterol becomes esterified for storage in
cytoplasmic lipid droplets (28). Alternatively, cholesterol de-
pletion and replacement may alter the selection of the endo-
cytic pathway that the virus takes in normal cells, namely, the
rapid clathrin pathway and, as a less efficient alternative, a
cholesterol-independent pathway. This possibility has recently
been illustrated for the transforming growth factor  receptor,
which can be internalized by either a clathrin- or raft-depen-
dent pathway (11). The clathrin pathway leads the transform-
ing growth factor  receptor into signaling endosomes,
whereas the raft pathway accelerates receptor degradation.
Accordingly, Ad2 might be taken up through the clathrin path-
way to signaling plasma membrane domains or endosomes,
facilitating the proper execution of endosomal escape.
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